Literature DB >> 26409505

What immunosuppression should be used for old-to-old recipients?

Yannick Le Meur1.   

Abstract

Elderly patients receiving a kidney from old donors (old-to-old) are a growing population of transplant recipients. This population cumulates risks of complications due to the co-morbidities and the immunodeficiency state and the frailty of the recipients together with the kidney senescence of the donors. In this context, the choice of immunosuppression is complicated and must take into account some contradictory principles explaining why no consensus exists today.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26409505     DOI： 10.1016/j.trre.2015.08.004

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN： 0955-470X            Impact factor:   3.943


  5 in total

1.  Recipient efficacy and safety of kidney transplantation from older living donor: consideration for using older kidney as a solution to the shortage of organs.

Authors:  Ji Yeon Song; Kyo Won Lee; Kyunga Kim; Kyeong Deok Kim; Jaehun Yang; Ji Eun Kwon; Okjoo Lee; Jae Berm Park
Journal:  Korean J Transplant       Date:  2021-12-31

2.  Elderly kidney transplant recipients have favorable outcomes but increased infection-related mortality.

Authors:  Jeong-Hoon Lim; Ga Young Lee; Yena Jeon; Hee-Yeon Jung; Ji-Young Choi; Jang-Hee Cho; Sun-Hee Park; Yong-Lim Kim; Hyung-Kee Kim; Seung Huh; Eun Sang Yoo; Dong-Il Won; Chan-Duck Kim
Journal:  Kidney Res Clin Pract       Date:  2022-02-23

3.  The Value of Older Donors' Klotho Level in Predicting Recipients' Short-Term Renal Function.

Authors:  Gengguo Deng; Anli Yang; Jiaqing Wu; Jiexue Zhou; Shandong Meng; Chunli Zhu; Jianfu Wang; Sheng Shen; Juan Ma; Dong Liu
Journal:  Med Sci Monit       Date:  2018-11-05

4.  Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR).

Authors:  Susanne Brakemeier; Wolfgang Arns; Frank Lehner; Oliver Witzke; Oliver Vonend; Claudia Sommerer; Anja Mühlfeld; Thomas Rath; Robert Schuhmann; Bianca Zukunft; Irena Kroeger; Martina Porstner; Klemens Budde
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

Review 5.  Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients.

Authors:  Amelia R Cossart; Nicole M Isbel; Carla Scuderi; Scott B Campbell; Christine E Staatz
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.